SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)

[NEWS RELEASEystar Bio-Pharmaceutical Reports First Quarter 2011 Results $7.0 Million Top Line; $0.27 Diluted EPS; Reiterates Fiscal 2011 Top Line Guidance range of $60 Million to $63 Million XIAN, CHINA May 23, 2011 --Skystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ( First Quarter 2011 Highlights Revenuereases 46% YoY to $7.0 million Veterinary vaccines totaled $0.3 million, up 30% YoY]

By | 2016-02-05T03:37:41+00:00 May 24th, 2011|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: NEWS RELEASEystar Bio-Pharmaceutical Reports First Quarter 2011 Results

[NEWS RELEASEystar Bio-Pharmaceutical Reports First Quarter 2011 Results $7.0 Million Top Line; $0.27 Diluted EPS; Reiterates Fiscal 2011 Top Line Guidance range of $60 Million to $63 Million XIAN, CHINA May 23, 2011 --Skystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ( First Quarter 2011 Highlights Revenuereases 46% YoY to $7.0 million Veterinary vaccines totaled $0.3 million, up 30% YoY]

By | 2016-02-05T03:38:33+00:00 May 24th, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SCOK [Hongli Clean Energy Technologies] 8-K: (Original Filing)

[SINOCOKING COAL AND COKE CHEMICAL INDUSTRIES, INC. OBTAINS NEW BUSINESS LICENSES FOR THREE COAL MINE COMPANIES IN BAOFENG COUNTY PINGDINGSHAN, China – May 23, 2011 - SinoCoking Coal and Coke Chemical Industries, Inc. (Nasdaq:SCOK) (the "Company" or "SinoCoking"), In August 2010, the Company announced that Henan Pingdingshan Hongli Coal & Coking Co., Ltd. (“Hongli”), which the Company controls through contractual] [Item 8.01 Other Events. Number Description]

SCOK [Hongli Clean Energy Technologies] 8-K: SINOCOKING COAL AND COKE CHEMICAL INDUSTRIES, INC. OBTAINS

[SINOCOKING COAL AND COKE CHEMICAL INDUSTRIES, INC. OBTAINS NEW BUSINESS LICENSES FOR THREE COAL MINE COMPANIES IN BAOFENG COUNTY PINGDINGSHAN, China – May 23, 2011 - SinoCoking Coal and Coke Chemical Industries, Inc. (Nasdaq:SCOK) (the "Company" or "SinoCoking"), In August 2010, the Company announced that Henan Pingdingshan Hongli Coal & Coking Co., Ltd. (“Hongli”), which the Company controls through contractual] [Item 8.01 Other Events. Number Description]

EGT [Entertainment Gaming Asia] 8-K: SHAREHOLDERS AGREEMENT Agreement 16 This Shareholders Agreement (the

[SHAREHOLDERS AGREEMENT Agreement 16 This Shareholders Agreement (the “ th day of May, 2011 by and between: 1. ELIXIR GAMING TECHNOLOGIES (CAMBODIA) CO., LIMITED, Chung Yuk Man (“EGT”) a Cambodian private limited company incorporated under the laws of the Kingdom of Cambodia under the number Co. 4497/08E on January 18, 2008, having its registered address at Suite No. 8 &] [CONTACTS: Entertainment Gaming Asia Inc. Traci Mangini tracimangini@EGT-Group.com 312/867-0848 ENTERTAINMENT GAMING ASIA ANNOUNCES PLANS TO DEVELOP AND OPERATE A NEW CASINO PROJECT IN THE PAILIN PROVINCE OF CAMBODIA NEAR THE THAILAND BORDER - New Strategic Project Marks Continued Progress in Casino Development Growth Strategy with Goal to Become a Leading Owner and Operator of Casinos in Indo China - Hong] [CONTACTS: Entertainment Gaming Asia Inc. Traci Mangini tracimangini@EGT-Group.com 312/867-0848 ENTERTAINMENT GAMING ASIA REPORTS FIRST QUARTER 2011 RESULTS AND PROVIDES MARKET UPDATE - Record Gaming Participation Revenue Drives Strong Adjusted EBITDA and Positive GAAP Earnings for the Quarter — Hong Kong — May 16, 2011 — Entertainment Gaming Asia Inc. (NYSE Amex: EGT) (“Entertainment Gaming Asia” or “the Company”), a leading] [ENTERTAINMENT GAMING ASIA INC. Nevada 001-32161 91-1696010 (State or Other Jurisdiction of (I.R.S. Employer Identification Unit 3705, 37/F, The Centrium 60 Wyndham Street Central, Hong Kong + 852-3151-3800 Not applicable (Former name or former address, if changed since last report) o o o o]

By | 2016-03-14T01:35:15+00:00 May 20th, 2011|Categories: Chinese Stocks, EGT, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[TPI Reports Record Third Quarter Fiscal Year 2011 Financial Results May 16, 2011 CHENGDU, China, May 16, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, announced the financial results for the third quarter of Fiscal Year 2011. Third quarter fiscal] [Tianyin Pharmaceutical, Inc. Third Quarter Fiscal Year 2011 Earnings Results May 17, 2011 Operator: Good morning, ladies and gentleman, and thank you for standing by. And welcome to the Tianyin Pharmaceutical Incorporated Third Quarter 2011 Earnings Conference Call. At this time, all participants are in a listen-only mode, and following the presentation, instructions will be given for the question-and-answer session.] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT May 16, 2011 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 Item 7.01. Regulation]

By | 2016-03-27T20:52:27+00:00 May 20th, 2011|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: TPI Reports Record Third Quarter Fiscal Year 2011

[TPI Reports Record Third Quarter Fiscal Year 2011 Financial Results May 16, 2011 CHENGDU, China, May 16, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, announced the financial results for the third quarter of Fiscal Year 2011. Third quarter fiscal] [Tianyin Pharmaceutical, Inc. Third Quarter Fiscal Year 2011 Earnings Results May 17, 2011 Operator: Good morning, ladies and gentleman, and thank you for standing by. And welcome to the Tianyin Pharmaceutical Incorporated Third Quarter 2011 Earnings Conference Call. At this time, all participants are in a listen-only mode, and following the presentation, instructions will be given for the question-and-answer session.] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT May 16, 2011 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 Item 7.01. Regulation]

By | 2016-03-27T20:53:58+00:00 May 20th, 2011|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments

CHLN [China Housing & Land Development] 8-K: (Original Filing)

[China Housing & Land Development Inc. Announces First Quarter 2011 Financial Results Xi’an, China – May 16, 2011 Highlights for Q1 2011: · Total revenue in the first quarter of 2011 decreased 37.4% to $22.6 million from $36.1 million in the fourth quarter of 2010 and decreased 32.8% from $33.6 million in the first quarter of 2010. · Total gross] [China Housing and Land Development, Inc. First Quarter 2011 Earnings Teleconference Script May 16, 2011 Operator: And now, at this time, I would like to turn the call over to Mr. Bill Zima of ICR for opening remarks and introductions. Bill Zima: Xiaohong Feng: 大家好,感谢大家参加今天的电话会议。总体来说,第一季度我们受到了一定的挑战,由于受到中央政府以及地方政府的一系列调控政策的影响,我们的销售未能达到预期。 Hello, everyone, and thank you for joining us for the call today. Overall, the first] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest Reported Event): May 20, 2011 (May 16, 2011) CHINA HOUSING & LAND DEVELOPMENT, INC. Nevada 000-51429 20-1334845 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 6 Youyi Dong Lu, Han Yuan 4 Lou Xi'An, Shaanxi Province, China 710054 (Zip Code) 86-029-82582632 ( N/A (Former Name]

Skip to toolbar